LABEXA

LABEXA: "With four subsidiaries (ACCOLAB, EXALAB, LBA, and SEALAB), LABEXA is the number one in Medical Biology in Nouvelle Aquitaine. The group LABEXA is a medical biology group, with a strong regional presence (number one in Aquitaine) and common values. Our 4 subsidiaries ACCOLAB, EXALAB, LBA, and SEALAB are located in the southwest of France. With over 900 collaborators, including more than 100 biologists, and 98 sites spread across the regional territory, we are dedicated to 'Your Health, Our Commitment'."

History: LABEXA was founded in 2001, anticipating the consolidation needs of the private medical biology sector. Initially, LABEXA consisted of a single multi-site laboratory (LBM), EXALAB, operating in Bordeaux and its surroundings. It expanded to the Gironde and Landes departments. In 2015, the group expanded with the arrival of the LBA laboratory, extending its activities to Lot et Garonne and Gers. Further growth came with the addition of LBM SEALAB in the Pyrénées-Atlantiques and ACCOLAB SUD OUEST sites in 2019. In early 2022, LABEXA was acquired by CERBA, becoming the 8th Cerballiance territory, named Cerballiance Nouvelle Aquitaine. The subsidiaries were then rebranded under the Cerballiance network, strengthening its position as the leading Medical Biology group in Nouvelle Aquitaine.

Key Information: Founded in 2001, LABEXA operates in the Health Care industry, headquartered in France. Despite the absence of recent investment details, the company has established a strong regional presence and experienced significant growth through strategic acquisitions, making it an attractive prospect for potential investors seeking to capitalize on the thriving medical biology sector in Nouvelle Aquitaine.